Table 1.
Author, year | Location | Acronym | Recruitment | Baseline year | Follow-up (months) | Loss at follow-up | Covariatesa | Risk of bias |
---|---|---|---|---|---|---|---|---|
Everard et al.18 2020 | USA | PATH | National cohort with non-institutionalized adults (≥18 years old) | 2013–2014 | 36 | NI | Age, sex, race/ethnicity, education, family income, use of other tobacco products, internalizing/externalizing/substance use problems and past cigarette use behavior | Moderate |
McMillen et al.20 2019 | USA | PATH | National cohort with non-institutionalized adults (≥18 years old) | 2013–2014 | 12 | 16.9% | Age, sex, race/ethnicity, education, household smoking rules and cohabitation with smokers | High |
Verplaetse et al.21 2019 | USA | PATH | National cohort with non-institutionalized adults (≥18 years old) | 2013–2014 | 12 | NI | Age, sex, race/ethnicity and education | High |
Brose et al.22 2019* | UK | - | National general population sample of smokers, former smokers and vapers (≥18 years old) | 2016 | 16 | 48.4% | Age, sex, annual income, duration of cessation, use of NRT and characteristics of e-cigarette use | Moderate |
Dai et al.19 2019* | USA | PATH | National cohort with non-institutionalized adults (≥18 years old) | 2013–2014 | 12 | 16.9% | Age, sex, race/ethnicity, education, family income, health insurance and region | Low |
Gomajee et al.16 2019* | France | CONSTANCES | National sample of adults (18–69 years old) from a compulsory health insurance (85% of population coverage) | 2015 | 22 (mean) | 1.0% | Age, sex, marital status, education, income, use of alcohol, number of cigarettes smoked at baseline, number of packs/year, duration of previous attempts to quit and comorbidities (depression, respiratory disorders) | Low |
PATH: Population Assessment of Tobacco and Health Study. NRT: nicotine replacement therapy. NI: not informed.
Included in the quantitative synthesis (meta-analysis).
Included in the multivariate model of the original study